Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems -: Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor

被引:31
作者
Schanstra, JP
Duchene, J
Praddaude, F
Bruneval, P
Tack, I
Chevalier, J
Girolami, JP
Bascands, JL [1 ]
机构
[1] CHU Rangueil, Inst Louis Bugnard, INSERM, U388, F-31052 Toulouse, France
[2] Hop Broussais, INSERM, U430, F-75674 Paris 14, France
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2003年 / 284卷 / 06期
关键词
kidney; hemodynamics; nitric oxide; backcross; genetic background;
D O I
10.1152/ajpheart.01150.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bradykinin B-2 receptor knockout mice (B-2(-/-))have been useful to study the role of bradykinin under pathological conditions. With the use of these mice, it was shown that bradykinin plays an important role in angiogenesis, heart failure, salt-induced hypertension, and kidney fibrosis. Data on the role of the bradykinin B-2 receptor under physiological conditions using these mice are controversial and scarce, because these mice have no typical phenotype. For this reason, we have studied, under physiological conditions, renal hemodynamics as well as a number of morphometric glomerular parameters of B-2(-/-) mice on a homogenized genetic background and on mice bred in a pathogen-free environment. Backcrossed B-2(-/-) mice had normal blood pressure and normal apparent renal hemodynamics and morphology. However, reduced renal nitrite excretion and glomerular cGMP content were found, which was associated with a reduced glomerular capillary surface area. These differences had, however, no detectable effects on renal hemodynamics. These differences between B-2(-/-) and wild-type mice might become important under pathological conditions as shown by a number of studies using these bradykinin B-2 receptor knockout mice.
引用
收藏
页码:H1904 / H1908
页数:5
相关论文
共 32 条
[21]  
REGOLI D, 1980, PHARMACOL REV, V32, P1
[22]   In vivo bradykinin B2 receptor activation reduces renal fibrosis [J].
Schanstra, JP ;
Neau, E ;
Drogoz, P ;
Gomez, MAA ;
Novoa, JML ;
Calise, D ;
Pecher, C ;
Bader, M ;
Girolami, JP ;
Bascands, JL .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (03) :371-379
[23]  
Schanstra JP, 2000, J AM SOC NEPHROL, V11, P1208, DOI 10.1681/ASN.V1171208
[24]   RENAL KALLIKREIN-KININ SYSTEM [J].
SCICLI, AG ;
CARRETERO, OA .
KIDNEY INTERNATIONAL, 1986, 29 (01) :120-130
[25]   Viewpoint: Are studies in genetically altered mice out of control? [J].
Sigmund, CD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1425-1429
[26]   Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B2 receptor pathway [J].
Silvestre, JS ;
Bergaya, S ;
Tamarat, R ;
Duriez, M ;
Boulanger, CM ;
Levy, BI .
CIRCULATION RESEARCH, 2001, 89 (08) :678-683
[27]   EVIDENCE THAT INTRARENAL BRADYKININ PLAYS A ROLE IN REGULATION OF RENAL-FUNCTION [J].
SIRAGY, HM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :E648-E654
[28]   Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelin(B) receptor [J].
Tack, I ;
MarinCastano, E ;
Bascands, JL ;
Pecher, C ;
Ader, JL ;
Girolami, JP .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (03) :433-440
[29]   Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice [J].
Trabold, F ;
Pons, S ;
Hagege, AA ;
Bloch-Faure, M ;
Alhenc-Gelas, F ;
Giudicelli, JF ;
Richer-Giudicelli, C ;
Meneton, P .
HYPERTENSION, 2002, 40 (01) :90-95
[30]   Enhanced renal function in bradykinin B2 receptor transgenic mice [J].
Wang, DZ ;
Yoshida, H ;
Song, Q ;
Chao, L ;
Chao, J .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (03) :F484-F491